These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17305594)

  • 1. Development and current status of unconventional platinum anticancer complexes.
    Abu-Surrah AS
    Mini Rev Med Chem; 2007 Feb; 7(2):203-11. PubMed ID: 17305594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum group antitumor chemistry: design and development of new anticancer drugs complementary to cisplatin.
    Abu-Surrah AS; Kettunen M
    Curr Med Chem; 2006; 13(11):1337-57. PubMed ID: 16712474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platinum-based anticancer agents: innovative design strategies and biological perspectives.
    Ho YP; Au-Yeung SC; To KK
    Med Res Rev; 2003 Sep; 23(5):633-55. PubMed ID: 12789689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug discovery research in in-vivo antitumor-active azolato-bridged dinuclear Pt(II) complexes].
    Komeda S
    Yakugaku Zasshi; 2012; 132(3):253-9. PubMed ID: 22382827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
    Lazarević T; Rilak A; Bugarčić ŽD
    Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monofunctional platinum(II)-based anticancer agent from a salicylanilide derivative: Synthesis, antiproliferative activity, and transcription inhibition.
    Wang B; Wang Z; Ai F; Tang WK; Zhu G
    J Inorg Biochem; 2015 Jan; 142():118-25. PubMed ID: 25450026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer metallotherapeutics in preclinical development.
    Kaluderović GN; Paschke R
    Curr Med Chem; 2011; 18(31):4738-52. PubMed ID: 21919843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dinuclear platinum anticancer complexes with fluorescent N,N'-bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles.
    Kalayda GV; Jansen BA; Wielaard P; Tanke HJ; Reedijk J
    J Biol Inorg Chem; 2005 May; 10(3):305-15. PubMed ID: 15824924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum(IV)-nitroxyl complexes as possible candidates to circumvent cisplatin resistance in RT112 bladder cancer cells.
    Cetraz M; Sen V; Schoch S; Streule K; Golubev V; Hartwig A; Köberle B
    Arch Toxicol; 2017 Feb; 91(2):785-797. PubMed ID: 27307157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancements in the Use of Platinum Complexes as Anticancer Agents.
    Sharma R; Singh VJ; Chawla PA
    Anticancer Agents Med Chem; 2022; 22(5):821-835. PubMed ID: 34353272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design of dicarboxylato platinum(II) complexes with purine-mimetic ligands as novel anticancer agents.
    Hoffmann K; Wiśniewska J; Wojtczak A; Sitkowski J; Denslow A; Wietrzyk J; Jakubowski M; Łakomska I
    J Inorg Biochem; 2017 Jul; 172():34-45. PubMed ID: 28477537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonclassical platinum antitumor agents: perspectives for design and development of new drugs complementary to cisplatin.
    Farrell N
    Cancer Invest; 1993; 11(5):578-89. PubMed ID: 8402226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in multinuclear complexes as potential anticancer and DNA binding agents.
    Wang K; Gao E
    Anticancer Agents Med Chem; 2014 Jan; 14(1):147-69. PubMed ID: 23869783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
    Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research progress in modern structure of platinum complexes.
    Bai L; Gao C; Liu Q; Yu C; Zhang Z; Cai L; Yang B; Qian Y; Yang J; Liao X
    Eur J Med Chem; 2017 Nov; 140():349-382. PubMed ID: 28985575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules.
    Savić A; Marzo T; Scaletti F; Massai L; Bartoli G; Hoogenboom R; Messori L; Van Deun R; Van Hecke K
    Biometals; 2019 Feb; 32(1):33-47. PubMed ID: 30367340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.
    Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N
    J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular shape and the field similarities as criteria to interpret SAR studies for fragment-based design of platinum(IV) anticancer agents. Correlation of physicochemical properties with cytotoxicity.
    Lorenzo J; Montaña ÁM
    J Mol Graph Model; 2016 Sep; 69():39-60. PubMed ID: 27567201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of novel azole-bridged dinuclear platinum(II) anticancer drugs to DNA: insights from hybrid QM/MM molecular dynamics simulations.
    Magistrato A; Ruggerone P; Spiegel K; Carloni P; Reedijk J
    J Phys Chem B; 2006 Mar; 110(8):3604-13. PubMed ID: 16494416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status of non-classical mononuclear platinum anticancer drug development.
    Zhang J; Liu D; Li Y; Sun J; Wang L; Zang A
    Mini Rev Med Chem; 2009 Oct; 9(11):1357-66. PubMed ID: 19929810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.